Full spectrum vs broad spectrum CBD: what is the difference and what to choose

After four weeks of taking full-spectrum oil, 7 out of 14 participants in the clinical trial tested positive for THC metabolite in urine. The daily dose of THC was 0.80 mg, and no one reported intoxication (Dahlgren et al., JAMA Psychiatry, 2021). This is the most practical difference between full spectrum and broad spectrum, and at the same time, one that you won't read on the label. Instead, the argument about the entourage effect is repeated, which sounds scientific but still remains a hypothesis without confirmation in a randomized study in humans. This article separates both layers: what is known from data about the three types of extract and what is merely probable. At the end, you will find a selection rule based on whether you are subject to testing, not on the promise of synergy.

KEY INFORMATION
• After 4 weeks of full-spectrum preparation, with 0.80 mg of THC daily, 7 out of 14 people had a positive urine test (Dahlgren et al., JAMA Psychiatry, 2021).
• The entourage effect is a hypothesis. There is a lack of randomized studies comparing full extract with isolate in humans.
• In 20 people using broad spectrum for 2 weeks, no THC or metabolites were detected (Zvorsky et al., 2025).
• The THC content in the bottle is confirmed solely by the certificate of analysis.

What is the difference between full spectrum, broad spectrum, and CBD isolate?

Full spectrum is an extract that retains the entire plant profile along with trace amounts of THC. Broad spectrum is the same extract after THC has been removed. Isolate is pure cannabidiol with a purity of 99% or more, without terpenes and other cannabinoids. Thus, these three names describe three levels of purification of the same raw material.

Hemp (L.) has been associated with humans for at least 10,000 years, and traces of its use have been discovered in Neolithic archaeological sites in Zhejiang province, China (Cannabis sativa Cannabis sativa (L.) produces over a hundred cannabinoids and about two hundred terpenes. Supercritical carbon dioxide or ethanol extraction pulls this entire mixture from the dried plant at once. Only subsequent stages determine the trade name: partial purification from waxes and chlorophyll yields full spectrum, selective chromatography removing THC yields broad spectrum, and crystallization leads to an isolate in the form of a white powder, which is then dissolved in MCT oil or hemp oil.

It's worth addressing one pricing myth. Isolate is often described as a cheaper and weaker variant, while its production requires additional purification stages and equipment that full spectrum does not need. The price difference of the semi-finished product arises from the market, not from the quality of the raw material.

Czy efekt entourage jest udowodniony?

No. The entourage effect is a hypothesis, not a conclusion. It assumes that cannabinoids and terpenes work together more effectively than separately, but there is no randomized study comparing full extract with isolate in humans. All arguments are based on review papers, animal models, and observational data.

The term itself originated in 1998 in a preclinical study on endocannabinoids, where inactive metabolites enhanced the effect of the active compound. It was transferred to cannabis Russo (British Journal of Pharmacology, 2011) in the review "Taming THC." There, he described limonene, myrcene, alpha-pinene, linalool, and beta-caryophyllene as compounds with their own pharmacological action that may sensibly contribute to the effect of the extract. This was a literature review proposing a mechanism, not a comparative experiment, and Russo himself framed it as a possibility.

Twenty years later, the balance of evidence looks modest. Christensen i in. (Biomedicines, 2023) They reviewed works both supporting and challenging this concept. Conclusion: the literature is in its infancy, preclinical and clinical studies rely on simplified methods and yield conflicting results, and patient data is mainly anecdotal. The authors directly propose that instead of a separate term, we should simply talk about synergy and biopotentiation, known from other herbal medicines.

The strongest evidence comes from mice. LaVigne i in. (Scientific Reports, 2021) They demonstrated that alpha-humulene, geraniol, linalool, and beta-pinene induce cannabinoid-like behaviors in rodents, and when administered together with an agonist, they sum their effects. This provides conceptual support for the hypothesis, not proof of efficacy in humans.

What did the Pamplona meta-analysis show regarding drug-resistant epilepsy?

The only concrete clinical data comparing full extract with pure CBD in humans comes from an observational meta-analysis. Pamplona i in. (Frontiers in Neurology, 2018) They gathered 11 studies and 670 patients with drug-resistant epilepsy to check if a CBD-rich extract performs better than a purified preparation.

The outcome depends on what we consider effectiveness. Any improvement in seizure frequency was reported by 71% of patients on extracts compared to 46% on pure CBD. At the standard clinical threshold, which is a reduction in seizures by at least half, the difference disappears: 37% versus 42%, with no statistical significance. At that point, 39% of all subjects were considered responders.

Another striking number is this: the average daily dose was 6.0 mg/kg for extracts and 25.3 mg/kg for pure CBD. Mild adverse effects were reported by 76% of individuals on the purified preparation compared to 33% on extracts, and severe effects were reported by 26% and 7%, respectively. The authors themselves note that the cause may be synergy with other phyto-compounds, but this requires confirmation in controlled studies.

We noticed that this second result is often cited out of context. Patients on pure CBD are largely participants in registration trials with intentionally high doses, while those on extracts adjusted their doses themselves. Thus, the fourfold difference in dosage is partly a difference in protocol, not in pharmacology.

Can full spectrum yield a positive THC test result?

Yes, and this is the best-documented practical difference between types of extract. Dahlgren i in. (JAMA Psychiatry, 2021) They administered a full-spectrum preparation to participants in an open study for four weeks. After this time, 7 out of 14 people, or half, tested positive for THC-COOH in urine.

The conditions of this study were very conservative. The preparation contained 9.97 mg/ml CBD and 0.23 mg/ml THC, which is 0.02% THC, well below the threshold of 0.3%. Participants took an average of 34.73 mg of CBD and 0.80 mg of THC per day, and all had a negative test result before starting and did not use other cannabis products. The screening test results were confirmed by gas chromatography with mass spectrometry. The only variable associated with THC status was creatinine concentration, indicating hydration and kidney function.

For comparison Zvorsky i in. (Experimental and Clinical Psychopharmacology, 2025) For two weeks, they administered a broad spectrum product to 20 healthy individuals at a dose of 34.20 mg of CBD per day. Neither THC nor its metabolites were detected in the urine of anyone. The study was shorter and smaller, but the direction of the result is clear. Participants also reported less sleep disturbance and reduced pain, with no adverse events.

The conclusion for the reader is uncomfortable for marketing. A legal full-spectrum oil, taken as recommended by the manufacturer and causing no intoxication, can lead to a positive test result at work after a month. This risk is real, measurable, and independent of whether the entourage hypothesis proves true. Timing also matters: THC metabolites accumulate in fatty tissue with daily use, so a single dose and a month of regular use are two different situations. We described the details of the testing procedures in the article. CBD and drug tests.

Dla kogo full spectrum, a dla kogo broad spectrum?

The choice hinges on one question, not a comparison of promises. If you are subject to substance testing, take broad spectrum or isolate. If you are not, full spectrum is a reasonable choice, although its advantage over broad spectrum is currently based on hypothesis rather than comparative study results.

Groups for whom the answer is predetermined in favor of a THC-free product:

• Kierowcy zawodowi and individuals driving company vehicles, where zero tolerance applies.
• Pracownicy testowani okresowo, especially in transport, industry, and security.
• Athletes subject to anti-doping regulations, as cannabidiol is excluded from the list of prohibited substances, while THC is not.
• Pregnant and breastfeeding women, for whom there is a lack of safety data for any dose of THC.
• Parents administering the product to a child, only after consulting with the attending physician.

Aside from these groups, the difference boils down to two minor details. Broad spectrum has a slightly milder taste because the process of removing THC also takes away some volatile components. Full spectrum can be cheaper with the same declared CBD content because it skips one processing step. Effectiveness cannot be determined today by data, so treat both as equivalent and decide based on the risk profile. If you switch products and notice a significant change in effect, check the terpene profile in the analysis certificates of both batches. The difference often arises from the strain of cannabis used for extraction rather than the presence or absence of trace THC. The choice of concentration is a separate matter, described in the article. Which CBD concentration to choose.

Kiedy izolat CBD ma sens?

Isolate is chosen for predictability, not potency. It contains 99% or more cannabidiol, so the dose in milligrams is exactly what is stated on the label, without variability from terpenes and other cannabinoids. It works well wherever variability in composition is a hindrance.

The first reason is zero tolerance for THC, stricter than for broad spectrum, where the notation 'below the limit of detection' depends on the sensitivity of the laboratory method. The second is taste: isolate dissolved in MCT oil is practically odorless and tasteless, which can be decisive for individuals who instinctively reject the bitter, earthy aftertaste of full extracts. The third is dosing precision when trying to combine CBD with pharmacotherapy, always under medical supervision, where any additional component complicates the assessment of interactions.

The opposing argument usually states that isolate does not provide the entourage effect. It is hard to treat this as a criticism since the effect itself has not been demonstrated in humans under controlled conditions. A fairer formulation would be: isolate forgoes potential benefits, the magnitude of which has not yet been measured, in exchange for certainty regarding composition. Data from a meta-analysis from Pamplona suggest that higher doses may be needed with purified CBD, but this observation comes from studies on drug-resistant epilepsy at doses several times higher than supplemental doses. Transferring this to 25 mg daily for sleep issues is an overreach that the data alone do not justify. If you want to check the difference on yourself, change one thing at a time: for four weeks, note the effect with the current product, then for another four with the new one, keeping the same dose in milligrams.

What do terpenes, CBG, and CBN do in the extract?

They add their pharmacological action, although in amounts that are rarely stated on the label. The best-documented example is beta-caryophyllene, a terpene with a peppery scent, also present in cloves and hops. Its mechanism has been precisely understood and is undisputed.

Gertsch i in. (PNAS, 2008) They demonstrated that beta-caryophyllene selectively binds to the CB2 receptor and acts as its agonist, inhibiting the production of pro-inflammatory cytokines in human blood. In mice lacking the CB2 receptor, the anti-inflammatory effect disappeared, which closes the proof of the mechanism. This is a single component with confirmed action, not proof of synergy of the entire extract.

The situation is worse with other cannabinoids. Nachnani i in. (Journal of Pharmacology and Experimental Therapeutics, 2021) They described cannabigerol as a molecule with an interesting receptor profile, intermediate between THC and CBD, with distinct affinity for alpha-2 adrenergic receptors and serotonin 5-HT1A receptors. However, they noted that there has been little research on CBG, and marketing has outpaced science.

The reputation of cannabinol as the 'cannabinoid of sleep' is even weaker. Corroon (Cannabis and Cannabinoid Research, 2021) He searched the literature and found eight studies meeting the criteria, mostly from the 1970s and 1980s, on small groups. No clinical study has compared CBN with a sleep questionnaire or polysomnography. The author's conclusion was clear: there is simply a lack of evidence for the sleep-inducing effect of CBN. You can find more about CBG itself in the article. CBG vs. CBD, properties and differences.

How to check what is really in the bottle?

Only through the certificate of analysis linked to the batch number on the label. Color, density, and intensity of smell carry no information about THC content. Two oils that look identical may differ in that one will pass a work test, and the other will not.

In the certificate, check three things. The batch number must match the one on the bottle, as a document from a year ago describes a different raw material. For THC, look for a specific number or the notation ND, meaning not detected, along with the stated limit of detection of the method. Compare the CBD content with the declaration on the packaging, as a discrepancy of more than a few percent indicates poor production control.

Separately about the 0.3% threshold, which is often misunderstood. It refers to the dry mass of the cultivated plant and determines the allowance of the variety for cultivation, not the THC content in the finished oil. The content in the product depends on the degree of concentration of the extract, and it is this that determines the test result. The study by Dahlgren et al. clearly demonstrated this: the preparation had 0.02% THC, fifteen times less than the limit for raw material, yet half of the participants tested positive.

Treat storage the same for all three types. A dark, cool place, a tightly sealed bottle, and the expiration date read from the packaging, not from general advice. Full extracts in hemp oil have more unsaturated fatty acids than isolate in MCT oil, so they lose freshness more quickly after opening.

Frequently Asked Questions

Czy efekt entourage jest udowodniony naukowo?

No. The term was described Russo (British Journal of Pharmacology, 2011) in the review work, and Christensen i in. (Biomedicines, 2023) they summarized the available data as scarce, methodologically simplified, and contradictory. There is no randomized study comparing full extract with isolate in humans.

Can full spectrum CBD give a positive THC test result?

Tak. W badaniu Dahlgren i in. (JAMA Psychiatry, 2021) After four weeks of full-spectrum preparation, 7 out of 14 participants tested positive for THC-COOH in urine, despite a dose of 0.80 mg of THC per day. The result was confirmed by gas chromatography with mass spectrometry.

Czy full spectrum CBD odurza?

Not at typical supplemental doses. In the same four-week study, with 0.80 mg of THC and about 35 mg of CBD daily, no participant reported any psychoactive effect or serious adverse event. However, the absence of intoxication does not mean that THC will not appear in urine.

Which to choose: full spectrum or broad spectrum?

This resolves the question about testing. If you are subject to testing at work, on the road, or in sports, choose broad spectrum or isolate. If you are not subject to testing, full spectrum is a reasonable choice, although its advantage is based on the entourage hypothesis rather than comparative data in humans.

Kiedy izolat CBD jest lepszym wyborem?

When you need a precisely known dose in milligrams, zero THC content, or a neutral taste. Isolate contains 99% or more cannabidiol, without terpenes and other cannabinoids. It is also a choice for those who do not tolerate the intense plant taste of full-spectrum extracts.

How to distinguish full spectrum from broad spectrum when purchasing?

Only with an analysis certificate linked to the batch number. Full spectrum will show measurable THC, broad spectrum will show ND or a value below the method's limit of detection. The appearance, color, and consistency of the oil say nothing about THC content, so the label itself does not confirm anything.

You will find oils in both variants, with analysis certificates for each batch, in the section hemp oils in the u Bucha store.

This article is informational and educational in nature. It contains internal links to products available in the u Bucha store. Prices and specifications may change - please check the current data on the product page before purchasing.

Author: Michał Waluk · Opublikowano: 2026-06-22 · Aktualizacja: 2026-08-07